SABTX
Price
$30.70
Change
+$0.21 (+0.69%)
Updated
Aug 21 closing price
Net Assets
639.03M
VIVIX
Price
$88.30
Change
+$0.49 (+0.56%)
Updated
Aug 21 closing price
Net Assets
256.41B
Interact to see
Advertisement

SABTX vs VIVIX

SABTX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
SABTX vs. VIVIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SABTX is a Hold and VIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 256B vs. SABTX (639M). VIVIX pays higher dividends than SABTX: VIVIX (1.86) vs SABTX (1.22). SABTX was incepted earlier than VIVIX: SABTX (27 years) vs VIVIX (28 years). SABTX (0.74) is less costly to investors than VIVIX (0.03). SABTX is a more actively managed with annual turnover of: 11.00 vs. VIVIX (8.00). SABTX has a lower initial minimum investment than VIVIX: SABTX (100000) vs VIVIX (5000000). SABTX annual gain was more profitable for investors over the last year : 32.18 vs. VIVIX (25.14). VIVIX (61.65) and SABTX (59.67) have equivalent 5 years return.
SABTXVIVIXSABTX / VIVIX
Total Expense Ratio0.740.032,467%
Annual Report Gross Expense Ratio0.740.032,467%
Fund Existence27 years28 years-
Gain YTD24.79718.508134%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets639M256B0%
Annual Yield % from dividends1.221.8666%
Returns for 1 year32.1825.14128%
Returns for 3 years70.8460.57117%
Returns for 5 years59.6761.6597%
Returns for 10 years109.80157.7070%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHRAX95.851.11
+1.17%
ClearBridge Growth A
GSVRX17.540.08
+0.46%
Goldman Sachs Large Cap Value R
IYEFX12.610.05
+0.40%
Nomura Climate Solutions R
CADRX26.440.09
+0.34%
Columbia Large Cap Growth Opp Inst2
PRWCX38.840.05
+0.13%
T. Rowe Price Capital Appreciation